X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (129) 129
Journal Article (49) 49
Book / eBook (3) 3
Publication (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (129) 129
hygiene (129) 129
medical or veterinary science (129) 129
preparations for medical, dental, or toilet purposes (129) 129
chemistry (116) 116
metallurgy (116) 116
organic chemistry (116) 116
peptides (111) 111
specific therapeutic activity of chemical compounds ormedicinal preparations (75) 75
animals (18) 18
mice (17) 17
humans (16) 16
cell line, tumor (13) 13
oncology (13) 13
cancer (12) 12
female (10) 10
index medicus (10) 10
invasion (8) 8
expression (7) 7
heterocyclic compounds (7) 7
in-vivo (6) 6
metastasis (6) 6
mice, nude (6) 6
gene expression (5) 5
matrix metalloproteinases (5) 5
xenograft model antitumor assays (5) 5
beer (4) 4
biochemistry (4) 4
biochemistry & molecular biology (4) 4
cancer cells (4) 4
carcinoma (4) 4
care and treatment (4) 4
cell biology (4) 4
cell proliferation (4) 4
development and progression (4) 4
enzymology (4) 4
gene expression regulation, neoplastic (4) 4
growth (4) 4
identification (4) 4
liver neoplasms - secondary (4) 4
liver neoplasms, experimental - secondary (4) 4
lymphoma (4) 4
lymphoma, t-cell - enzymology (4) 4
lymphoma, t-cell - pathology (4) 4
matrix metalloproteinase 9 - genetics (4) 4
matrix metalloproteinase inhibitors (4) 4
mice, inbred dba (4) 4
microbiology (4) 4
mutation or genetic engineering (4) 4
neoplasm transplantation (4) 4
proteases (4) 4
research (4) 4
spirits (4) 4
tissue inhibitor of metalloproteinase-1 - biosynthesis (4) 4
tumors (4) 4
vinegar (4) 4
wine (4) 4
analysis (3) 3
angiogenesis (3) 3
antibodies, monoclonal - immunology (3) 3
antineoplastic agents - pharmacology (3) 3
breast cancer (3) 3
breast-cancer (3) 3
cancer-therapy (3) 3
cell lines (3) 3
cells (3) 3
compositions thereof (3) 3
culture media (3) 3
high-titer (3) 3
liver metastasis (3) 3
liver neoplasms - metabolism (3) 3
liver neoplasms - pathology (3) 3
liver neoplasms, experimental - enzymology (3) 3
liver neoplasms, experimental - prevention & control (3) 3
lung cancer (3) 3
lymphoma, t-cell - drug therapy (3) 3
matrix metalloproteinase 9 - biosynthesis (3) 3
matrix-metalloproteinase inhibitors (3) 3
medicine, research & experimental (3) 3
metastases (3) 3
microorganisms or enzymes (3) 3
mmp-9 (3) 3
neoplasms (3) 3
neoplasms - drug therapy (3) 3
physiological aspects (3) 3
plasminogen activation system (3) 3
propagating, preserving or maintaining microorganisms (3) 3
proteins (3) 3
receptors, cell surface - metabolism (3) 3
receptors, urokinase plasminogen activator (3) 3
retroviral vectors (3) 3
rna, messenger - genetics (3) 3
timp-1 (3) 3
tissue inhibitor of metalloproteinase-1 - genetics (3) 3
tissue inhibitor of metalloproteinase-1 - metabolism (3) 3
tissue inhibitors (3) 3
tumor cell lines (3) 3
tumor invasion (3) 3
urokinase (3) 3
urokinase-type plasminogen activator - antagonists & inhibitors (3) 3
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (155) 155
French (30) 30
German (19) 19
Spanish (19) 19
Chinese (18) 18
Portuguese (7) 7
Korean (4) 4
Japanese (3) 3
Ukrainian (2) 2
Croatian (1) 1
Danish (1) 1
Greek (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Polish (1) 1
Russian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Cancer, ISSN 0020-7136, 09/2019, Volume 145, Issue 5, pp. 1346 - 1357
Journal Article
Nature, ISSN 0028-0836, 02/2019, Volume 566, Issue 7744, pp. 403 - 406
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 665 - 665
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 05/2017, Volume 16, Issue 5, pp. 893 - 904
C4.4A (LYPD3) has been identified as a cancer-and metastasisassociated internalizing cell surface protein that is expressed in non-small cell lung cancer... 
C4.4A | ONCOLOGY | MARKER | MOLECULE | CLONING | POOR-PROGNOSIS | UROKINASE RECEPTOR | HOMOLOG | IDENTIFICATION | EXPRESSION | CARCINOMA | Cisplatin - immunology | Humans | Cell Adhesion Molecules - antagonists & inhibitors | Aminobenzoates - immunology | Cell Adhesion Molecules - immunology | Vinblastine - administration & dosage | Immunoconjugates - administration & dosage | Cisplatin - administration & dosage | Immunoconjugates - immunology | Vinblastine - analogs & derivatives | Paclitaxel - immunology | Vinblastine - immunology | GPI-Linked Proteins - antagonists & inhibitors | Paclitaxel - administration & dosage | Oligopeptides - chemistry | Antibodies, Monoclonal - immunology | GPI-Linked Proteins - immunology | Carcinoma, Non-Small-Cell Lung - genetics | Oligopeptides - immunology | Immunoconjugates - chemistry | Carcinoma, Non-Small-Cell Lung - immunology | Xenograft Model Antitumor Assays | Animals | Aminobenzoates - chemistry | Antibodies, Monoclonal - administration & dosage | Cell Line, Tumor | Mice | Carcinoma, Non-Small-Cell Lung - drug therapy | Cell proliferation | Squamous cell carcinoma | Effectiveness | Lung cancer | Keratinocytes | Non-small cell lung carcinoma | Cytotoxicity | Tissues | Cell surface | Cisplatin | Endothelial cells | Metastases | Esophagus | Anticancer properties | Lungs | Cell lines | Paclitaxel | Xenografts | Monoclonal antibodies | Antitumor activity | Skin | Vinorelbine | Cancer
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 5880 - 5880
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 4333 - 4333
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 12/2010, Volume 14, Issue 12, pp. 2760 - 2770
Paradoxically, not only proteinases but also their inhibitors can correlate with bad prognosis of cancer patients, underlining the evolving concept of the... 
TIMP-1 | Protease web | HGF | Scattering | Liver metastasis | UPA | MEDICINE, RESEARCH & EXPERIMENTAL | liver metastasis | uPA | HEPATOCYTE GROWTH-FACTOR | HIGH-TITER | RETROVIRAL VECTORS | MET RECEPTOR | CELL BIOLOGY | BREAST-CANCER | MATRIX METALLOPROTEINASES | protease web | scattering | GENE-EXPRESSION | CYSTATIN-C | LYMPHOMA | XENOGRAFT MODEL | Cell Line | Prognosis | Signal Transduction | Humans | Gene Expression Regulation, Neoplastic | Gene Silencing | Hepatocyte Growth Factor - metabolism | Mice, Knockout | Tissue Inhibitor of Metalloproteinase-1 - genetics | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Liver - immunology | Animals | Urokinase-Type Plasminogen Activator - metabolism | Fluorescent Antibody Technique | HEK293 Cells | Liver Neoplasms - metabolism | Cell Line, Tumor | Mice | Liver Neoplasms - secondary | Granulocytes - immunology | Tissue inhibitor of metalloproteinases | Liver | Parenchyma | Metastasis | Metastases | Urokinase | Signal transduction | Proteolysis | Conflicts of interest | Growth factors | Hepatocyte growth factor | Cloning | Neutrophils | Leukocytes (neutrophilic) | Gene expression | Ablation | Lymphoma | U-Plasminogen activator | Gene silencing | Signaling | Inhibitors | Medical prognosis | Lymphomas | Leukocytes (granulocytic) | Cancer | Tumors | Proteins | Proteases | Rodents
Journal Article
Journal Article
Cell Death and Disease, ISSN 2041-4889, 2017, Volume 8, Issue 3, pp. e2716 - e2716
Journal Article
Molecular cancer therapeutics, ISSN 1535-7163, 11/2018, Volume 17, Issue 11, pp. 2285 - 2296
The lactate transporter SLC16A1/monocarboxylate transporter 1 (MCT1) plays a central role in tumor cell energy homeostasis. In a cell-based screen, we... 
TARGET | POTENT | DISRUPTION | ONCOLOGY | MCT1 | SENSITIVITY | CANCER METABOLISM | TUMOR-CELLS | HYPOXIA | SUBUNIT | AZD3965
Journal Article
Cancer Medicine, ISSN 2045-7634, 02/2015, Volume 4, Issue 2, pp. 253 - 267
Molecular mechanisms underlying the development of resistance to platinum‐based treatment in patients with ovarian cancer remain poorly understood. This is... 
GDF | AKT | ovarian cancer | linear model analysis | platinum resistance | Platinum resistance | Linear model analysis | GDF15 | Ovarian cancer | CELLS | ACTIVATION | DETERMINANTS | MACROPHAGE INHIBITORY CYTOKINE-1 | DNA-DAMAGE | RISK | CISPLATIN | ONCOLOGY | RESISTANCE | EXPRESSION | MOLECULAR-MECHANISMS | Oligonucleotide Array Sequence Analysis | Humans | Carboplatin - administration & dosage | Gene Expression Profiling | Antineoplastic Agents - administration & dosage | Mice, SCID | Growth Differentiation Factor 15 - genetics | Gene Knockdown Techniques | Ovarian Neoplasms - genetics | Xenograft Model Antitumor Assays | Cell Movement - drug effects | Animals | Cell Line, Tumor | Female | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Mice | Carboplatin - pharmacology | Ovarian Neoplasms - drug therapy | Cyclin-Dependent Kinase Inhibitor p27 - genetics | Drug Resistance, Neoplasm - drug effects | Care and treatment | RNA | Growth | Analysis | Genomics | Tumor proteins | Cancer | Cell proliferation | Cell culture | p53 Protein | DNA damage | AKT protein | Genomes | Cancer therapies | DNA repair | Phase transitions | Proteins | Platinum | Cell cycle | Deoxyribonucleic acid--DNA | Cell survival | Histology | Gene expression | Chemotherapy | Molecular modelling | DNA microarrays | Carboplatin | Plasma levels | Cell size | Cell migration | Tumors | Original Research | Cancer Biology
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 02/2012, Volume 11, Issue 2, pp. 340 - 349
Journal Article